Invasive pneumococcal disease may be the first sign of undiagnosed blood cancers and antibody deficiencies in adults, a new study finds.
|Articles|November 15, 2021
Daily OTC Pearl: Tums (Calcium Carbonate)
Author(s)Saro Arakelians, PharmD
Tums treats symptoms such as heartburn, upset stomach, or indigestion.
Advertisement
OTC/Lifestyle Pearl of the Day: Tums (Calcium Carbonate)
Indication: Tums is used to treat symptoms caused by excess
Insight:
- Tums is an antacid that works by lowering the amount of acid in the
stomach . - Directions to use: For the chewable form, chew the
medication well before swallowing. For the liquid form, shake the bottle well before each dose. - Adverse effects may include constipation, gas, burping, nausea/vomiting, weight loss, muscle pain, weakness, and possible kidney issues.
- Interactions: Some products that may interact with this drug include
digoxin , certain phosphate binders (such ascalcium acetate), phosphatesupplements (such aspotassium phosphate), and sodium polystyrene sulfonate. - Dosage forms: Tums are available in smoothies, tablets, and chewable forms. They also come in sugar-free form for patients such as diabetics, chewy tablets with mint, regular and extra strength.
Sources:
Advertisement
Related to this article
A new analysis finds a significant weight loss edge for tirzepatide under one estimand but not another; no head-to-head trial exists at these doses.
In SCOUT-HCM, mavacamten reduced the Valsalva LVOT gradient by 48 mm Hg versus placebo in adolescents. REMS, echo monitoring, and CYP interactions still apply in the new population.
Indirect comparison links orforglipron 17.2 mg to 1.5% more weight loss and 0.3% more A1C lowering than oral semaglutide 25 mg in adults with type 2 diabetes.
Pharmacists can help overcome influenza vaccine hesitancy by correcting common misconceptions, routinely asking every patient about vaccination, and leveraging their standing as trusted health care professionals.
Phase 3 TRIUMPH-2 data presented at EASD show HbA1c reductions up to 1.6%, with GI effects, hypotension, and dysesthesia as key counseling points.
In a FINE-HEART analysis, cancer history raised the risk of death and hospitalization but did not blunt finerenone's cardiovascular and kidney benefits.
Hemoglobin, platelets, bleeding, pericardial effusions, and intrapulmonary shunting top the monitoring list for patients with pulmonary arterial hypertension (PAH) starting with sotatercept, according to Vallerie McLaughlin, MD.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Intensive Chemotherapy in Combination With Quizartinib Versus Midostaurin for FLT3-ITD Mutated Acute Myeloid Leukemia: A Multicenter Cohort Study
2
September 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
3
Orforglipron Edges Oral Semaglutide 25 mg in T2D, Indirect Comparison Finds
4
Retatrutide Cuts Weight Up to 18.8% in Adults With T2D, Obesity
5